-
-
-
-
-
-
-
Novelion Therapeutics (NVLN) Subsidiary Aegerion Pharmaceuticals, Inc. Signs Licensing Agreement with Recordati Rare Diseases Inc. for JUXTAPID in Japan
-
-
-
-
-
-
-
Novelion Therapeutics Announces Next Phase of Operational Improvements
-
-
-
-
-
-
-
Novelion Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
-
-
-
-
-
-
-
Novelion Therapeutics Reports First Quarter 2017 Financial Results
-
-
-
-
-
1,200,013 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

